Academic Rank:
Professor, UBC
Senior Scientist, Deeley Research Centre; Director, Tumour Tissue Repository, BC Cancer Victoria Centre
Affiliation(s):
BC Cancer Agency, Victoria Centre
Dept. of Biochemistry and microbiology, University of Victoria
Short Bio:

Dr. Peter H. Watson is a Professor in the Department of Pathology, BC Cancer and the University of British Columbia and he is director of the BC Cancer Biobanking and Biospecimen Research Services.

Dr. Watson combines a clinical practice as a breast pathologist with a research laboratory based at the Deeley Research Center and an interest in the molecular pathology of solid tumors and in the development of biobank resources for health research. His laboratory made early contributions to approaches and application of molecular technologies to tissues and the program currently focuses specifically on the biology of biomarkers of breast tumour progression and the role of immune-tumor interactions in determining response to therapies.

In addition to directing the BC Cancer Biobanking and Biospecimen Research Services Program and he leads the Canadian Tumour Repository Network (CTRNet) .

Academic background

  • BA (Natural Sciences), Cambridge University, 1978
  • MA, Cambridge University, 1982
  • MB BChir, Cambridge University, 1983
  • FRCPC (Anatomic Pathology), University of Manitoba, 1988

Research Interest

  • Primary Research Area Molecular Pathology and Cell Biology Cancer
  • Secondary Research Area Education and Utilization Research
  • Cancer
  • Diagnostic Breast Pathology
  • Anatomic Pathology

Dr Peter Watson’s Laboratory:
Our laboratory is located at the Deeley Research Center, BC Cancer Victoria Center (https://www.bccrc.ca/dept/drc/). Our focus is on the molecular pathology of breast cancer.. The training experience in the laboratory is enhanced by several parameters. These include the translational research emphasis, a close relationship with the Tumor Tissue Repository (https://www.bccrc.ca/dept/drc/services/biobanking-and-biospecimen-research-services) and active interactions and collaborations with other cancer research laboratories and groups within the BC Cancer and other institutions.